A lipoprotein(a) level of 61 nmol/L is good – it falls well below the risk thresholds and indicates low cardiovascular risk from Lp(a).
Understanding Your Lp(a) Result
Your level of 61 nmol/L places you in the low-risk category for Lp(a)-mediated cardiovascular disease. Here's the clinical context:
Risk Stratification Based on Guidelines
The most recent 2024 NLA guidelines establish clear risk categories 1:
- Low risk: <75 nmol/L (your level falls here)
- Intermediate risk: 75-125 nmol/L
- High risk: ≥125 nmol/L (50 mg/dL)
The traditional threshold for "elevated" Lp(a) has been >75 nmol/L, which approximates the 75th percentile in white populations and reflects epidemiological CVD risk thresholds 2. European guidelines suggest significant risk begins at >100-125 nmol/L 2.
What This Means Clinically
At 61 nmol/L, you are:
- Below all major risk thresholds used in clinical practice
- In the lower half of the population distribution for Lp(a)
- Not at increased cardiovascular risk from Lp(a) specifically
Important Context
While your Lp(a) is reassuring, remember that:
- Lp(a) is only one cardiovascular risk factor – traditional risk factors (LDL cholesterol, blood pressure, diabetes, smoking) still require management
- Lp(a) levels are genetically determined and remain stable throughout life, so repeat testing is generally not needed unless there's a specific clinical indication
- Recent research shows that even patients with Lp(a) <65 nmol/L can develop cardiovascular disease, though at lower rates than those with elevated levels 3
No Special Management Needed
With your Lp(a) level, no Lp(a)-specific interventions are warranted. Focus should remain on standard cardiovascular risk factor management through lifestyle modification and treatment of other lipid abnormalities if present. The 2024 guidelines reserve intensive Lp(a)-directed therapy for those with levels ≥125 nmol/L who are at high cardiovascular risk 1.